BE727109A - - Google Patents

Info

Publication number
BE727109A
BE727109A BE727109DA BE727109A BE 727109 A BE727109 A BE 727109A BE 727109D A BE727109D A BE 727109DA BE 727109 A BE727109 A BE 727109A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE727109A publication Critical patent/BE727109A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20Light-tight connections for movable optical elements
    • G02B7/22Extensible connections, e.g. bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
BE727109D 1968-01-19 1969-01-20 BE727109A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
BE727109A true BE727109A (en:Method) 1969-07-22

Family

ID=9751941

Family Applications (1)

Application Number Title Priority Date Filing Date
BE727109D BE727109A (en:Method) 1968-01-19 1969-01-20

Country Status (14)

Country Link
US (1) US3721687A (en:Method)
BE (1) BE727109A (en:Method)
BR (1) BR6905681D0 (en:Method)
CA (1) CA952900A (en:Method)
CH (2) CH564563A5 (en:Method)
DK (1) DK126500B (en:Method)
ES (1) ES362679A1 (en:Method)
FR (1) FR2000443A1 (en:Method)
GB (1) GB1253831A (en:Method)
IE (1) IE33204B1 (en:Method)
IL (1) IL31447A (en:Method)
NL (1) NL6900795A (en:Method)
NO (1) NO132100C (en:Method)
SE (1) SE350035B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
WO2009045539A2 (en) 2007-10-05 2009-04-09 Nektar Therapeutics Al, Corporation Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
DK126500B (da) 1973-07-23
CA952900A (en) 1974-08-13
BR6905681D0 (pt) 1973-02-08
ES362679A1 (es) 1971-02-01
NO132100B (en:Method) 1975-06-09
IL31447A0 (en) 1969-03-27
IE33204L (en) 1969-07-19
GB1253831A (en) 1971-11-17
DE1902340B2 (de) 1977-06-08
CH564563A5 (en:Method) 1975-07-31
DE1902340A1 (de) 1969-09-11
IL31447A (en) 1973-11-28
IE33204B1 (en) 1974-04-17
CH564035A5 (en:Method) 1975-07-15
NL6900795A (en:Method) 1969-07-22
US3721687A (en) 1973-03-20
NO132100C (en:Method) 1975-09-17
FR2000443A1 (en:Method) 1969-09-05
SE350035B (en:Method) 1972-10-16

Similar Documents

Publication Publication Date Title
AU428130B2 (en:Method)
NO132100C (en:Method)
AU416157B2 (en:Method)
AU429879B2 (en:Method)
AU2581067A (en:Method)
AU421558B1 (en:Method)
AU2580267A (en:Method)
AU3224368A (en:Method)
AU3789668A (en:Method)
AU4744468A (en:Method)
BE727301A (en:Method)
BE726404A (en:Method)
BE728456A (en:Method)
AU4224469A (en:Method)
BE728379A (en:Method)
AU3083868A (en:Method)
AU4270368A (en:Method)
BE728333A (en:Method)
BE727676A (en:Method)
BE727415A (en:Method)
BE708888A (en:Method)
BE727263A (en:Method)
BE727220A (en:Method)
BE727044A (en:Method)
BE726933A (en:Method)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: GLAXO LABORATORIES LTD

Effective date: 19890120